angiopoietin-related protein 3; angiopoietin-like protein 3; angiopoietin-5; ANG-5 (ANGPTL3, ANGPT5, UNQ153/PRO179)
Jump to navigation
Jump to search
Function
- ANGPTL3 inhibits lipoprotein lipase & endothelial lipase[3]
Structure
- contains 1 fibrinogen C-terminal domain
Compartment
Expression
- expressed predominantly in liver
- weakly expressed in kidney
Pharmacology
- evinacumab-dgnb (Evkeeza) is a recombinant monoclonal Ab that binds to & inhibits angiopoietin-like 3 (ANGPTL3) FDA-approved for treatment of homozygous familial hypercholesterolemia
More general terms
References
- ↑ Entrez Gene http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=27329
- ↑ UniProt http://www.uniprot.org/uniprot/Q9Y5C1.html
- ↑ 3.0 3.1 Styles S FDA Approves Orphan Drug Evinacumab-dgnb for Homozygous FH Medscape - Feb 11, 2021. https://www.medscape.com/viewarticle/945719